| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |